Mentioned in this article
A rating of 100 puts Cidara Therapeutics Inc (CDTX) near the top of the Biotechnology industry according to InvestorsObserver. Cidara Therapeutics Inc’s score of 100 means it scores higher than 100% of stocks in the industry. Cidara Therapeutics Inc also received an overall rating of 90, putting it above 90% of all stocks. Biotechnology is ranked 39 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 90 would rank higher than 90 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What’s Happening With Cidara Therapeutics Inc Stock Today?
Cidara Therapeutics Inc (CDTX) stock is lower by -1.76% while the S&P 500 has gained 1.69% as of 1:18 PM on Thursday, Mar 16. CDTX is lower by -$0.03 from the previous closing price of $1.68 on volume of 1,308,945 shares. Over the past year the S&P 500 is lower by -9.19% while CDTX has gained 132.39%. CDTX lost -$0.53 per share the over the last 12 months.
Click Here to get the full Stock Report for Cidara Therapeutics Inc stock.